Jonathan Coslet - Cushman Wakefield Independent Director
| CWK Stock | USD 15.17 0.73 5.06% |
Director
Mr. Jonathan J. Coslet is Independent Director of the company since 2018. Mr. Coslet is a Senior Partner of TPG Global LLC . Mr. Coslet is also a member of the firms Investment Committee and Management Committee. Prior to joining TPG, he worked at Donaldson, Lufkin Jenrette, and before that, at Drexel Burnham Lambert, where he started his career. Mr. Coslet previously served on the board of directors of Biomet, Inc., IASIS Healthcare LLC, Quintiles IMS Holdings, Inc., Quintiles Transnational Holdings Inc., PETCO Animal Supplies, Inc. and Neiman Marcus Group, Inc. He currently serves on the boards of Life Time Fitness, Inc., IQVIA Holdings Inc., the Stanford Medical Advisory Council and the Stanford Institute for Economic Policy Research Advisory Board, and he serves as a Trustee for Menlo School since 2018.
| Age | 56 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Address | 125 Old Broad Street, London, United Kingdom, EC2N 1AR |
| Phone | 44 20 3296 3000 |
| Web | https://www.cushmanwakefield.com |
Cushman Wakefield Management Efficiency
The company has Return on Asset of 0.0279 % which means that on every $100 spent on assets, it made $0.0279 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0539 %, implying that it generated $0.0539 on every 100 dollars invested. Cushman Wakefield's management efficiency ratios could be used to measure how well Cushman Wakefield manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.04 this year, although the value of Return On Tangible Assets will most likely fall to (0.01). At this time, Cushman Wakefield's Non Current Liabilities Total is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 368.5 M this year, although the value of Total Current Liabilities will most likely fall to about 2.4 B.Similar Executives
| Found 1 records | DIRECTOR Age | ||
| CAIA CFA | Medalist Diversified Reit | N/A | |
Management Performance
| Return On Equity | 0.0539 | ||||
| Return On Asset | 0.0279 |
Cushman Wakefield plc Leadership Team
Elected by the shareholders, the Cushman Wakefield's board of directors comprises two types of representatives: Cushman Wakefield inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cushman. The board's role is to monitor Cushman Wakefield's management team and ensure that shareholders' interests are well served. Cushman Wakefield's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cushman Wakefield's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angelique Brunner, Independent Director | ||
| Duncan Palmer, Chief Financial Officer, Executive Vice President | ||
| Lincoln Pan, Independent Director | ||
| Angela Sun, Independent Director | ||
| Megan McGrath, Senior Relations | ||
| John Forrester, Executive Vice President and Global President | ||
| Brett White, Executive Chairman of the Board, Chief Executive Officer | ||
| Billie Williamson, Independent Director | ||
| Dan Broderick, President Advisory | ||
| Richard McGinn, Independent Director | ||
| Anthony Miller, Independent Director | ||
| Emily Kehinde, Chief Officer | ||
| Holly Tyson, Chief Officer | ||
| Jonathan Coslet, Independent Director | ||
| Mike Dunn, Las Principal | ||
| Jun Sochi, Managing Singapore | ||
| William White, Executive Chairman of the Board, CEO | ||
| Michelle MacKay, President, Chief Operating Officer | ||
| Noelle Perkins, General VP | ||
| Jodie McLean, Independent Director | ||
| Nathaniel Robinson, Executive Vice President — Strategic Planning and Chief Investment Officer | ||
| Leonard Texter, Chief Accounting Officer, Global Controller, Head - Investor Relations | ||
| Rajeev Ruparelia, Independent Director | ||
| Brett Soloway, Executive Vice President General Counsel, and Corporate Secretary | ||
| Brad Kreiger, Chief Officer | ||
| Matthew Bouw, Chief Pacific | ||
| Neil Johnston, Chief Financial Officer, Executive Vice President | ||
| Andrew Mcdonald, Global COO | ||
| Michelle Hay, Chief Human Resource Officer, Executive Vice President | ||
| Andrew Phipps, EMEA Development | ||
| Laurida Sayed, Chief Officer | ||
| Jeff Green, MD Group | ||
| Qi Chen, Independent Director | ||
| Sal Companieh, Chief Officer | ||
| Colin Wilson, Chief EMEA | ||
| Timothy Dattels, Lead Independent Director |
Cushman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cushman Wakefield a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0539 | ||||
| Return On Asset | 0.0279 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 5.91 B | ||||
| Shares Outstanding | 229.49 M | ||||
| Shares Owned By Insiders | 1.27 % | ||||
| Shares Owned By Institutions | 97.46 % | ||||
| Number Of Shares Shorted | 14.35 M | ||||
| Price To Earning | 10.71 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Real Estate Management & Development space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cushman Wakefield. If investors know Cushman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cushman Wakefield listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.948 | Earnings Share 0.38 | Revenue Per Share 41.049 | Quarterly Revenue Growth 0.025 | Return On Assets 0.0279 |
The market value of Cushman Wakefield plc is measured differently than its book value, which is the value of Cushman that is recorded on the company's balance sheet. Investors also form their own opinion of Cushman Wakefield's value that differs from its market value or its book value, called intrinsic value, which is Cushman Wakefield's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cushman Wakefield's market value can be influenced by many factors that don't directly affect Cushman Wakefield's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cushman Wakefield's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cushman Wakefield is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cushman Wakefield's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.